Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1670 participants.

Also called NCT06725810

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,670 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06725810
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06725810. Randomized; no masking; primary purpose treatment. Start 2025-03-27 (actual); primary completion 2029-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
Acronym
CANNON
Condition
Chronic Kidney Disease Associated Anemia
Intervention (Drug)
Enarodustat
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct06725810
Content hash
ddf30100400d76c51ef7f50e60f2299535ae73a5faad371dacfc3bbfea210773